1. Zhu, Yuqi, Lu, Yanxin, Xu, Chunhua, Xie, Xina, Li, Zesong. 2024. TMEM52B Isoforms P18 and P20 Differentially Promote the Oncogenesis and Metastasis of Nasopharyngeal Carcinoma. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2402457. doi:10.1002/advs.202402457. https://pubmed.ncbi.nlm.nih.gov/38940427/
2. Lee, Yunhee, Ko, Dongjoon, Yoon, Junghwa, Lee, Younghoon, Kim, Semi. 2021. TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activity. In Journal of experimental & clinical cancer research : CR, 40, 58. doi:10.1186/s13046-021-01828-7. https://pubmed.ncbi.nlm.nih.gov/33641663/
3. Lee, Yunhee, Ko, Dongjoon, Yoon, Junghwa, Kim, Semi. 2025. TMEM52B-derived peptides inhibit generation of soluble E-cadherin and EGFR activity to suppress colon cancer growth and early metastasis. In Journal of translational medicine, 23, 146. doi:10.1186/s12967-025-06075-4. https://pubmed.ncbi.nlm.nih.gov/40025509/
4. Zhou, Yong, Tong, Zhongkai, Zhu, Xiaoxiao, Zhou, Ying, Dong, Zhaoxing. 2025. Deciphering the cellular and molecular landscape of pulmonary fibrosis through single-cell sequencing and machine learning. In Journal of translational medicine, 23, 3. doi:10.1186/s12967-024-06031-8. https://pubmed.ncbi.nlm.nih.gov/39748378/